About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » News » Drug News » Barkin Didn't Correct Son for Smoking Drugs

Barkin Didn't Correct Son for Smoking Drugs

by Medindia Content Team on Jun 19 2007 5:47 PM

Barkin Didn

London, Actress Ellen Barkin who recently starred in 'Ocean's 13' did not scold her 18-year-old son, Jack, when he came home smelling of marijuana because she used to smoke it with her family.

The 53-year-old actress chose to ignore the incident even though she knew he was indulging in the bad habit, reports contactmusic.com.

She says: 'I used to smoke with my family. On Passover we would all smoke pot as a family.'

Source-IANS
LIN/J

Recommended Readings

Drug Toxicity

Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a drug, reaction to a drug or drug abuse.

PLAC Test for Cardiovascular Disease

PLAC Test for Cardiovascular Disease

Ensure your heart health by getting a PLAC test. Prevent heart attack and stroke by detecting your risk of developing cardiovascular disease.

Antioxidants to Help You When You Quit Smoking

Antioxidants to Help You When You Quit Smoking

Smoking is injurious to health, but it sure is a tough addiction to stop. Cure yourself with the power of antioxidants to eliminate health risks such as lung cancer and dental problems.

Smoking And Tobacco

Smoking And Tobacco

Encyclopedia section of medindia briefs you about the History of Tobacco

Smoking And Cancer

Smoking And Cancer

Smoking is the most important preventable cause of cancer in the world.

Leriche Syndrome

Leriche Syndrome

A patient with Leriche syndrome suffers from claudication symptoms, impotence and decreased pulses in the lower limbs.

Latest Drug News

Alectinib: Adjuvant Treatment for Lung Cancer Approved by US FDA

Alectinib: Adjuvant Treatment for Lung Cancer Approved by US FDA

Alectinib approved by US FDA for auxiliary treatment of patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) who underwent tumor resection.

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

The US FDA approves a immunotherapy drug, N-803, for BCG-unresponsive non-muscle invasive bladder cancer, suggested to be used in conjunction with BCG.

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

The increasing trend in strategic partnerships between innovator companies, and the US FDA approval for Rezdiffra has led to a boost in the development of medications for MASH.

Semaglutide: A Dominant Player for Patients With Heart Failure

Semaglutide: A Dominant Player for Patients With Heart Failure

Data provesSemaglutideefficacy in treatment of Type 2 diabetes, obesity, heart failure, and chronic kidney failure, it emerges as important therapy in metabolic syndrome.

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Generics are not widely used, despite cost advantage, due to a lack of information to patients and reluctance from physicians to prescribe generics - A Need to educate masses

Advertisement